Skip to content
Latest
Miami-Dade bitcoin tax payments reach county in dollars, not crypto The FDA now says Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss Micron stock falls 3%, why this analyst sees 140% upside for the stock? Even Wall Street’s lone Nvidia bear says forcing out CEO Jensen Huang ‘would be a mistake for everyone’ Take-Two Interactive Software stock rises 7.12% but faces $222.64 pivot Mercado Bitcoin to resume cash withdrawals after $49M hack MARA stock rises 5.95% intraday but remains below all three daily EMAs Pacific Imperial Announces Submission of NI 43-101 Technical Report for the Fenton Property and Update on the Reviewable Transaction and Property Update on the Babine Property Miami-Dade bitcoin tax payments reach county in dollars, not crypto The FDA now says Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss Micron stock falls 3%, why this analyst sees 140% upside for the stock? Even Wall Street’s lone Nvidia bear says forcing out CEO Jensen Huang ‘would be a mistake for everyone’ Take-Two Interactive Software stock rises 7.12% but faces $222.64 pivot Mercado Bitcoin to resume cash withdrawals after $49M hack MARA stock rises 5.95% intraday but remains below all three daily EMAs Pacific Imperial Announces Submission of NI 43-101 Technical Report for the Fenton Property and Update on the Reviewable Transaction and Property Update on the Babine Property
STOX.NEWS
In focus
BTC 85 POST 56 TLDR 46 NVDA 37 ETH 33 NXTT 23 NOV 22 XRP 19

The FDA now says Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss

MarketWatch
Image supplied by MarketWatch.
Advertisement
Demo creative for ADG7 Article top (728x90)

Several medical studies have found that people taking GLP-1 medications have an elevated risk for nonarteritic anterior ischemic optic neuropathy, or NAION.

Related video

Advertisement
Demo creative for ADG8 Article body (336x280)

More on this

Advertisement
Demo creative for ADG3 Footer banner (728x90)